Beyond Diversity: Focusing on and Enhancing Inclusion in the Society for Epidemiologic Research.


Journal

American journal of epidemiology
ISSN: 1476-6256
Titre abrégé: Am J Epidemiol
Pays: United States
ID NLM: 7910653

Informations de publication

Date de publication:
01 10 2020
Historique:
received: 15 03 2020
revised: 07 04 2020
accepted: 12 06 2020
pubmed: 1 7 2020
medline: 27 11 2020
entrez: 1 7 2020
Statut: ppublish

Résumé

Increasing diversity and inclusion among organizational membership has become a focus for many professional societies, including the Society for Epidemiologic Research (SER). In this issue of the Journal, DeVilbiss et al. (Am J Epidemiol. 2020:189(10):998-1010) assessed dimensions of diversity and inclusion within SER to provide baseline data for future evaluations of Society initiatives. In our response, we note that diversity in SER appears strong but there is lag with regard to inclusion. We also highlight some of the major weaknesses of this study that hinder efforts to accurately evaluate inclusion within SER. There is a need to more concretely define inclusion and think broadly about how measures of inclusion should be operationalized in future surveys. Additional limitations of the study include its limited generalizability to the wider SER membership and the lack of questions about barriers to inclusion in SER activities. We conclude with recommendations for SER and other professional societies based on prior literature evaluating successful diversity and inclusion efforts. We also propose a conceptual model to assist with operationalizing and directing future analyses of inclusion measures. It is essential that SER move beyond efforts around diversity to focus on measuring and enhancing inclusion.

Identifiants

pubmed: 32602893
pii: 5864912
doi: 10.1093/aje/kwaa111
pmc: PMC7666410
doi:

Types de publication

Editorial Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1042-1046

Subventions

Organisme : NCI NIH HHS
ID : T32 CA163184
Pays : United States

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health.

Références

Sci Adv. 2019 Oct 09;5(10):eaaw7238
pubmed: 31633016
PLoS One. 2013 Oct 30;8(10):e79147
pubmed: 24205372
CBE Life Sci Educ. 2018 Jun;17(2):ar32
pubmed: 29799320
Acad Med. 2020 May;95(5):710-716
pubmed: 31702694
Ann Epidemiol. 2019 Jul;35:1-3
pubmed: 31036443

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH